<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To compare effects of three different insulin secretagogues on early-phase insulin secretion, metabolism of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipids</z:chebi>, and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation in newly diagnosed Type 2 <z:hpo ids='HP_0000819'>Diabetes Mellitus</z:hpo> (T2DM) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Totally 60 newly diagnosed T2DM outpatients were randomized to three groups with 1-month monotherapy of repaglinide (Rg), <z:chebi fb="0" ids="5383">glimepiride</z:chebi> (Gm) or <z:chebi fb="0" ids="31654">gliclazide</z:chebi> <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> (Gli), respectively </plain></SENT>
<SENT sid="2" pm="."><plain>Some indexes of early-phase insulin secretion, <z:chebi fb="105" ids="17234">glucose</z:chebi>, <z:chebi fb="23" ids="18059">lipids</z:chebi>, and <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation were inspected </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> (FPG), glycosylated <z:chebi fb="0" ids="35143">hemoglobin</z:chebi> (HbA(1c)) and <z:chebi fb="0" ids="24103">fructosamine</z:chebi> (FA) were improved in <z:hpo ids='HP_0000001'>all</z:hpo> groups similarly (p&gt;0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>Rg group was with the highest early-phase insulin secretion index (DeltaI30/DeltaG30) (p=0.026), lower mean amplitude of glycaemic excursion (MAGE) (p&lt;0.05), lowest mean peak value of post-lunch <z:chebi fb="105" ids="17234">glucose</z:chebi> (p=0.043), and lowest postprandial <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (TG) (p=0.039) </plain></SENT>
<SENT sid="5" pm="."><plain>Postprandial free fatty acid (FFA) was lower after Rg and Gli treatment (p&lt;0.05) </plain></SENT>
<SENT sid="6" pm="."><plain>Serum 8-iso <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> F(2alpha) (8-iso <z:chebi fb="0" ids="26340">PGF</z:chebi>(2alpha)) was improved in <z:hpo ids='HP_0000001'>all</z:hpo> groups, but the improvement showed statistically significant only in Rg group (p=0.04) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Rg, Gm and Gli can <z:hpo ids='HP_0000001'>all</z:hpo> decrease blood <z:chebi fb="105" ids="17234">glucose</z:chebi> effectively in newly diagnosed T2DM patients, while Rg performs outstandingly in the aspects of improving early-phase insulin secretion, <z:chebi fb="105" ids="17234">glucose</z:chebi> excursion, postprandial <z:chebi fb="23" ids="18059">lipids</z:chebi> and 8-iso <z:chebi fb="0" ids="26340">PGF</z:chebi>(2alpha) </plain></SENT>
</text></document>